Tag: biotech
-
![Predictmedix (PMED.C) partners with India Fortune 500 Company]()
Predictmedix (PMED.C) partners with India Fortune 500 Company
Impairment is an expensive problem at the workplace and Predictmedix impairment detection technology is also designed to identify alcohol and cannabis impairment. The two Predictmedix technologies will be deployed at Indian Oil Bhawan, New Delhi within the next 3-4 weeks.
-
Perimeter Medical Imaging AI: Covering the Margin Calls for Cancer
For the last eight months, the Covid-19 virus has been the centre of attention in the media, the markets, and the medical field. Collectively, countries, government agencies, academic institutions and pharmaceutical companies across the world have poured hundreds of millions into efforts combating the viral outbreak that has left so many countries and populations struggling…
-
Valeo Pharma Inc. (VPH.C) – THE undervalued biotech play
If you’re one of the discerning readers who bought Valeo Pharma’s stock since the last article I posted on July 6th, 2020: congratulations you should be making over 38% returns on your investment. Better yet, if you had bought Valeo’s stock a month ago, you would have been up close to 184%, which, y’know, is…
-
ImmunoPrecise (IPA.V): when scientific breakthrough is executed strategically
You know what grinds my gears? The fact that investors will happily speculate on Tesla (TSLA.NYSE) stock because they think they understand the automobile market, but won’t attempt to do the due diligence for biotechs because it’s “too hard”.
-
Biotech: Who will survive when the Covid-19 Hype Ends? Part II
For part I of this series please click here. Cities across Canada are gradually returning to business as usual, and we’re winning the fight against Covid-19 (don’t look south of the border). Thanks to all citizens still wearing hats to hide their botched home-haircuts, and our essential workers who literally put their lives on the…
-
Leaping Forward: PredictMedix (PMED.C) partners with TechMahindra
Keynes once said that “the market can remain irrational longer than you can remain solvent”. Fundamentals departed market valuation long ago, but you could’ve at least expected market reaction to be in response to COVID-19 related news. Except it seems like that’s no longer the case.
-
Shroom Digest: Mushroom moves from MindMed, Yield Growth, New Wave, Yukoterre, Silo, EGF Theramed
This week’s digest of mushroom moves is a mixed bag of trash and glory, with the shrooms sector increasingly looking like the early days of the cannabis rush.
-
Predictmedix (PMED.C) inks deal to acquire a Telehealth company
Predictmedix and MobileWellbeing are attacking the Telehealth problem from different angles.
-
I asked Twitter what tickers I should be writing about: Twitter had 35 ideas… here’s 6 of them
Ever get the feeling, looking at your watchlist, that you’re seeing the same thing over and over? That maybe there’s interesting stuff out there you just haven’t heard about yet? I put a simple question to Twitter today: “Give me a ticker symbol you think I should be writing about (limit one per person), three…
-
Biotech: Who Will Survive When The COVID-19 Hype Ends?
Over the last couple of months, companies have found a way to muster up an effort to align their objectives with helping society recover from this global pandemic – COVID-19. The result: share prices have soared like never before. The line up of biotech companies trying to come up with COVID-19 vaccines or cures is…
